Nobel Pharmaceuticals   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Tokyo Japan (2003)
Status: No NME R&D (2003)

Organization Overview

First Clinical Trial
2004
NCT00212368
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Nobelpharma | Nobel Pharmaceuticals